Related Experiment Video
Updated: Jul 16, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Tyrosine kinase mutations in human cancer
Ernst Lengyel1, Kenjiro Sawada, Ravi Salgia
1University of Chicago, Department of Obstetrics and Gynecology, MC 2050, Section of Gynecologic Oncology, 5841 South Maryland Avenue, Chicago, IL 60637, USA. elengyel@uchicago.edu
Current Molecular Medicine
|February 22, 2007
Summary
Mutated tyrosine kinases drive cancer growth and spread. Understanding these mutations in kinases like EGFR and PI3-kinase helps develop targeted cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Tyrosine kinases are crucial signaling proteins implicated in cancer development.
- Mutations in tyrosine kinases can lead to uncontrolled cell growth, malignant transformation, and metastasis.
- Specific kinases like EGFR, c-Met, c-Kit, and PI3-kinase are frequently altered in human cancers.
Purpose of the Study:
- To review the role of specific mutated tyrosine kinases in human cancer.
- To discuss the impact of these mutations on tumor biology.
- To highlight how structural and functional insights into kinase mutations inform targeted treatment strategies.
Main Methods:
- Literature review focusing on tyrosine kinases (EGFR, c-Met, c-Kit, PI3-kinase) and their mutations in cancer.
- Analysis of the effects of mutations on kinase expression, conformation, and stability.
- Examination of the downstream signaling pathway alterations caused by mutated kinases.
Main Results:
- Mutations in EGFR, c-Met, c-Kit, and PI3-kinase are key drivers of cancer malignancy.
- Altered tyrosine kinases exhibit constitutive activation, promoting tumor growth and metastasis.
- Understanding kinase structure-function relationships is vital for designing effective targeted therapies.
Conclusions:
- Targeted therapies based on specific kinase mutations offer promising treatment avenues for cancer patients.
- Further research into tyrosine kinase biology and mutation impact is essential for advancing cancer treatment.
- Personalized medicine approaches leveraging knowledge of mutated kinases are transforming cancer care.
More Related Videos
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.